TY - JOUR
T1 - Human Tissues Contain CD141 hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103 + Nonlymphoid Dendritic Cells
AU - Haniffa, Muzlifah
AU - Shin, Amanda
AU - Bigley, Venetia
AU - McGovern, Naomi
AU - Teo, Pearline
AU - See, Peter
AU - Wasan, Pavandip Singh
AU - Wang, Xiao Nong
AU - Malinarich, Frano
AU - Malleret, Benoit
AU - Larbi, Anis
AU - Tan, Pearlie
AU - Zhao, Helen
AU - Poidinger, Michael
AU - Pagan, Sarah
AU - Cookson, Sharon
AU - Dickinson, Rachel
AU - Dimmick, Ian
AU - Jarrett, Ruth F.
AU - Renia, Laurent
AU - Tam, John
AU - Song, Colin
AU - Connolly, John
AU - Chan, Jerry K.Y.
AU - Gehring, Adam
AU - Bertoletti, Antonio
AU - Collin, Matthew
AU - Ginhoux, Florent
N1 - Funding Information:
This work was supported by The Wellcome Trust, UK (WT088555MA; M.H. and N.McG.); Singapore Immunology Network core grant (F.G., J.C., and L.R.); George Walker Fellowship and British Society for Haematology (V.B.); NMRC, Singapore (NMRC/CSA/012/2009; J.K.Y.C.); Leukaemia and Lymphoma Research UK (S.P.); and Histiocytosis Association and Histiocytosis Research Trust (M.C. and S.C.). We thank the following for assistance: M.L. Ng, S.H. Tan, and T.B. Lu from the Electron Microscopy Unit of the National University of Singapore; I. Harvey and O. Hughes at the Flow Cytometry Core Facility of the Faculty of Medicine Newcastle University; I. Low and N. Binte Shadan at the Flow Cytometry Core Service; J. Lum and F. Zolezzi at the Functional Genomics Laboratory of the Singapore Immunology Network; and Nikon Imaging Centre, Biopolis, Singapore. We thank the following for sharing reagents or materials: K. Shortman and M. Lahoud, Walter and Eliza Hall Institute, Melbourne; C. Reis e Sousa, Cancer Research UK, London; G. Brown, University of Aberdeen; S. Todryk, Northumbria University; and L. Mori and G. de Libero, Singapore Immunology Network.
PY - 2012/7/27
Y1 - 2012/7/27
N2 - Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8 + T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141 hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c + and CD14 + tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141 hi DCs were closely related to blood CD141 + DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting.
AB - Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8 + T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141 hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c + and CD14 + tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141 hi DCs were closely related to blood CD141 + DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting.
UR - http://www.scopus.com/inward/record.url?scp=84864293006&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2012.04.012
DO - 10.1016/j.immuni.2012.04.012
M3 - Article
C2 - 22795876
AN - SCOPUS:84864293006
SN - 1074-7613
VL - 37
SP - 60
EP - 73
JO - Immunity
JF - Immunity
IS - 1
ER -